AR224288A1 - Procedimiento para preparar composiciones de corticoesteroides-esteres de l-arginina acuosolubles - Google Patents

Procedimiento para preparar composiciones de corticoesteroides-esteres de l-arginina acuosolubles

Info

Publication number
AR224288A1
AR224288A1 AR283476A AR28347680A AR224288A1 AR 224288 A1 AR224288 A1 AR 224288A1 AR 283476 A AR283476 A AR 283476A AR 28347680 A AR28347680 A AR 28347680A AR 224288 A1 AR224288 A1 AR 224288A1
Authority
AR
Argentina
Prior art keywords
corticoesteroid
arginine
soluble
procedure
preparing water
Prior art date
Application number
AR283476A
Other languages
English (en)
Spanish (es)
Original Assignee
Italfarmaco Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Italfarmaco Spa filed Critical Italfarmaco Spa
Application granted granted Critical
Publication of AR224288A1 publication Critical patent/AR224288A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
AR283476A 1979-12-28 1980-12-04 Procedimiento para preparar composiciones de corticoesteroides-esteres de l-arginina acuosolubles AR224288A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT28417/79A IT1127322B (it) 1979-12-28 1979-12-28 Composizioni farmaceutiche con esaltazione dell'attivita' terapeutica di cortisonici

Publications (1)

Publication Number Publication Date
AR224288A1 true AR224288A1 (es) 1981-11-13

Family

ID=11223560

Family Applications (1)

Application Number Title Priority Date Filing Date
AR283476A AR224288A1 (es) 1979-12-28 1980-12-04 Procedimiento para preparar composiciones de corticoesteroides-esteres de l-arginina acuosolubles

Country Status (24)

Country Link
US (1) US4282217A (fr)
JP (1) JPS56103113A (fr)
AR (1) AR224288A1 (fr)
AU (1) AU524820B2 (fr)
BE (1) BE886758A (fr)
BR (1) BR8008493A (fr)
CA (1) CA1161362A (fr)
DE (1) DE3027039C2 (fr)
DK (1) DK524080A (fr)
ES (1) ES497508A0 (fr)
FI (1) FI803767L (fr)
FR (1) FR2472388A1 (fr)
GB (1) GB2066072B (fr)
GR (1) GR72504B (fr)
IE (1) IE50549B1 (fr)
IN (1) IN152354B (fr)
IT (1) IT1127322B (fr)
LU (1) LU83029A1 (fr)
NL (1) NL182775C (fr)
NO (1) NO803916L (fr)
PH (1) PH17384A (fr)
PT (1) PT72274B (fr)
SE (1) SE8009103L (fr)
ZA (1) ZA807516B (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1201511B (it) * 1985-12-23 1989-02-02 Italfarmaco Spa Derivati citoprotettivi in patologie a base ischemica,loro preparazione e composizioni che li cntengono
JPS6310084U (fr) * 1986-07-07 1988-01-22
US5312835A (en) * 1989-09-13 1994-05-17 Board Of Regents, The University Of Texas System Use of cardiotonic drugs and inhibitors of nitric oxide synthesis to alleviate pathologic hypotension
US5059712A (en) * 1989-09-13 1991-10-22 Cornell Research Foundation, Inc. Isolating aminoarginine and use to block nitric oxide formation in body
US5216025A (en) * 1989-09-13 1993-06-01 Board Of Regents, The University Of Texas System Nitric oxide synthesis inhibitors for potentiating the action of pressor agents in certain hypotensive patients
US5028627A (en) * 1989-09-13 1991-07-02 Cornell Research Foundation, Inc. Method of using arginine derivatives to inhibit systemic hypotension associated with nitric oxide production or endothelial derived relaxing factor
US5770623A (en) * 1989-09-13 1998-06-23 Board Of Regents, The University Of Texas System Argine antagonists for inhibition of systemic hypotension associated with nitric oxide production or endothelial derived relaxing factor
US5158883A (en) * 1989-09-13 1992-10-27 Cornell Research Foundation, Inc. Method of using aminoarginine to block nitric oxide formation in vitro
GB8929076D0 (en) * 1989-12-22 1990-02-28 Scras Treatment of shock by blocking agents of edrf effect or formation
US5196195A (en) * 1990-03-27 1993-03-23 Cornell Research Foundation, Inc. Use of arginase to control nitric oxide formation
US5395612A (en) * 1990-03-27 1995-03-07 Cornell Research Foundation, Inc. Method for treating systemic hypotension caused by sepsis or cytokine using arginase in combination with an α1 adrenergic agonist
SE468881B (sv) * 1991-01-09 1993-04-05 Kabi Pharmacia Ab Anvaendning av vissa foereningar foer framstaellning av laekemedel foer behandling av endotoxininducerade effekter samt saett att avlaegsna endotoxiner ur diverse loesningar
US5273875A (en) * 1991-03-22 1993-12-28 Cornell Research Foundation, Inc. N6 -(hydrazinoiminomethyl)lysine and method of inhibiting nitric oxide formation in body
US5132453A (en) * 1991-03-22 1992-07-21 Cornell Research Foundation, Inc. N6 -(hydrazinoiminomethyl)lysine and method of inhibiting nitric oxide formation in body
US5374651A (en) * 1991-09-27 1994-12-20 Board Of Regents, The University Of Texas System Methods and compositions for the treatment of hypotension with arginine free essential and essential amino acids and arginine derivatives
US5877176A (en) * 1991-12-26 1999-03-02 Cornell Research Foundation, Inc. Blocking induction of tetrahydrobiopterin to block induction of nitric oxide synthesis
JP2534423B2 (ja) 1991-12-26 1996-09-18 コーネル・リサーチ・ファンデーション・インコーポレイテッド 酸化窒素の過剰生産から生じる血管失調を阻止する阻害剤
US5281627A (en) * 1992-05-28 1994-01-25 Cornell Research Foundation, Inc. Substituted arginines and substituted homoarginines and use thereof
US5585402A (en) * 1992-12-23 1996-12-17 Glaxo Wellcome Inc. Nitric oxide synthase inhibitors
US20020031513A1 (en) * 1997-11-24 2002-03-14 Shamir Leibovitz Method and pharmaceutical composition for inhibiting premature rapture of fetal membranes, ripening of uterine cervix and preterm labor in mammals
KR100472303B1 (ko) * 2002-05-21 2005-03-08 김영미 결장표적성 프로드럭으로서의 코티코스테로이드21-설페이트 소듐 유도체
US8439922B1 (en) 2008-02-06 2013-05-14 NiVasive, Inc. Systems and methods for holding and implanting bone anchors
US9198698B1 (en) 2011-02-10 2015-12-01 Nuvasive, Inc. Minimally invasive spinal fixation system and related methods
US9486256B1 (en) 2013-03-15 2016-11-08 Nuvasive, Inc. Rod reduction assemblies and related methods
US9974577B1 (en) 2015-05-21 2018-05-22 Nuvasive, Inc. Methods and instruments for performing leveraged reduction during single position spine surgery
US10398481B2 (en) 2016-10-03 2019-09-03 Nuvasive, Inc. Spinal fixation system
US11051861B2 (en) 2018-06-13 2021-07-06 Nuvasive, Inc. Rod reduction assemblies and related methods

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3320125A (en) * 1964-04-28 1967-05-16 Merck & Co Inc Inhalation aerosol composition
CA939265A (en) * 1967-11-18 1974-01-01 Yoshitaka Ikezuki Injectable compositions for alleviating the pain incurred from administrations of injections
US3639585A (en) * 1968-03-29 1972-02-01 Res Inst Medicine Chem Method of preventing corticosteroid-induced adverse effects on bon and compositions useful in said method
JPS5035061A (fr) * 1973-07-28 1975-04-03

Also Published As

Publication number Publication date
BE886758A (nl) 1981-04-16
NL182775C (nl) 1988-05-16
FI803767L (fi) 1981-06-29
PT72274B (en) 1981-11-05
FR2472388A1 (fr) 1981-07-03
AU524820B2 (en) 1982-10-07
DK524080A (da) 1981-06-29
CA1161362A (fr) 1984-01-31
GB2066072A (en) 1981-07-08
US4282217A (en) 1981-08-04
IT7928417A0 (it) 1979-12-28
ES8205417A1 (es) 1982-06-16
NO803916L (no) 1981-06-29
FR2472388B1 (fr) 1983-04-01
JPS56103113A (en) 1981-08-18
GR72504B (fr) 1983-11-15
DE3027039C2 (de) 1984-05-17
IN152354B (fr) 1983-12-24
AU6502980A (en) 1981-07-02
ES497508A0 (es) 1982-06-16
IE50549B1 (en) 1986-05-14
BR8008493A (pt) 1981-07-14
IE802605L (en) 1981-06-28
ZA807516B (en) 1981-11-25
DE3027039A1 (de) 1981-07-02
LU83029A1 (de) 1981-03-27
NL182775B (nl) 1987-12-16
GB2066072B (en) 1984-02-01
JPS6144844B2 (fr) 1986-10-04
IT1127322B (it) 1986-05-21
NL8006707A (nl) 1981-07-16
SE8009103L (sv) 1981-06-29
PH17384A (en) 1984-08-06
PT72274A (en) 1981-01-01

Similar Documents

Publication Publication Date Title
AR224288A1 (es) Procedimiento para preparar composiciones de corticoesteroides-esteres de l-arginina acuosolubles
AR230178A1 (es) Procedimiento para preparar composiciones farmaceuticas
ES494352A0 (es) Procedimiento para preparar derivados de acidos quinolina- carboxilicos
ES497884A0 (es) Procedimiento para preparar derivados de 2-amino-4-hidroxi- quinazolina
AR230989A1 (es) Procedimiento para preparar acilureidoalquil-bencen-sulfonilureas
ES492943A0 (es) Procedimiento para preparar polieteres sililados
ES494279A0 (es) Precedimientos para preparar composiciones de derivados de feniletanolamina.
MX5880E (es) Procedimiento para preparar derivados de bencilimidazol
ES492255A0 (es) Procedimiento para preparar aroilimidazol-2-onas
ES488635A0 (es) Procedimiento para preparar derivados de pirimidina
ES494119A0 (es) Procedimiento para preparar derivados de 3-aminoproxiarilo
MX6816E (es) Procedimiento para preparar quinolonas
AR229084A1 (es) Procedimiento para preparar composiciones de contraste para angiografia
ES488772A0 (es) Procedimiento para preparar derivados de pirimidona
MX7642E (es) Procedimiento para preparar la 1-ciclo-hexenilmentil-2-cloroetil pirrolidina
ES489689A0 (es) Procedimiento para preparar compuestos de isotiourea
MX6141E (es) Procedimiento para preparar acil-ureas
MX6405E (es) Procedimiento para preparar tiazolilideno-oxo-propionitrilos
MX6024E (es) Procedimiento para preparar 2-cloro-4-hidroximetil-tiazoles-5-substituidos
ES493499A0 (es) Procedimiento para preparar compuestos de 3-metilemazetidina
ES492394A0 (es) Procedimiento para preparar derivados de pirimidina
MX6971E (es) Procedimiento para preparar derivados de tetrahidroquinolina
ES489932A0 (es) Procedimiento para la preparacion de fertilizantes
ES492692A0 (es) Procedimiento para preparar derivados de benoimidazol
ES496518A0 (es) Procedimiento para preparar bencil-oximeteres trisustituidos